Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|39|1|38-46

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.39, Iss.1, 2018-01, pp. : 38-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant*

By Wu Sharon K.   Ann David K.   Kim Kwang-Jin   Lee Vincent H. L.  

Journal of Drug Targeting, Vol. 13, Iss. 8-9, 2005-09 ,pp. : 521-533

Informa Healthcare

Access to resources Recommend Favorite

Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 123-129

Bentham Science Publishers

Access to resources Recommend Favorite

Genomics and Proteomics of Nucleoside Transporters

By  

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney

By Mangravite L.M.   Badagnani I.   Giacomini K.M.  

European Journal of Pharmacology, Vol. 479, Iss. 1, 2003-10 ,pp. : 269-281

Elsevier

Access to resources Recommend Favorite

Interaction of Nucleoside Analogues with Nucleoside Transporters in Rat Brain Endothelial Cells

By Chishty Mansoor   Begley David J.   Abbott N. Joan   Reichel Andreas  

Journal of Drug Targeting, Vol. 12, Iss. 5, 2004-06 ,pp. : 265-272

Informa Healthcare

Access to resources Recommend Favorite